Common Names: China root
Novel phenylpropanoids from Smilax china L. showed significant cytotoxicity against HeLa cells, impacting mitochondrial function, ROS levels, cell migration, and cell-cycle progression. Compound 13 could be a promising treatment for cervical cancer.
Researchers studied the plant Smilax china L. (Jingangteng) and its use in treating gynecological inflammation. They found that Jingangteng capsules may regulate glucose and lipid metabolism, providing potential health benefits.
Smilax china L., a commonly used traditional Chinese medicine, effectively treats pelvic inflammation and other inflammatory disorders, making it relevant for research and potential application in the lab.
SCP, derived from Smilax china L., reduces insulin resistance and obesity in mice by regulating gene and protein expressions involved in metabolism. It may have potential therapeutic value for lifestyle diseases.